Vorinostat After Stem Cell Transplant in Treating Patients With High-Risk Lymphoma
Clinical trial NCT00561418 · COMPLETED
Trial details
- NCT number
- NCT00561418
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2012-11-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.